Susan Hasty, Publisher
Table of Contents . . . March 18th, 1996Non-Subscriber - Summaries Only
Conference Coverage (NCVDG) - Gamma Interferon Gene Adds to Attenuation and Efficacy of Live Vaccine
Conference Coverage (NCVDG) - Live Attenuated SIV Vaccine Safe In Neonates At Normal Doses
Conference Coverage (NCVDG) - NIAID Announces AIDS Vaccine Prevention and Research Program (VPRP)
Antisense Technology - Human Interferon-Gamma Inhibited by Antisense RNA Gene Therapy
Breast Cancer (Genetics) - Full Sequence of BRCA2 Cancer Gene Published
Cancer Gene Therapy - Oral Administration of Ganciclovir Effective with HSV-TK Gene Therapy
Chemoprotection - Gene Transfer of Human ATase in BM Protects Against Alkylating Agents
HIV Gene Therapy - Targeting Hematopoietic Stem Cells
Industry News (Funding) - Drug Firm Becomes First Private Entity To Fund Gene-Map Research
Industry News (Funding) - First Scientific Milestone in Alliance Completed
Industry News (Joint Venture) - Collaboration Announced To Develop DNA Sequencing Technology
Liver Disease - Genetics Study Eyes Therapy To Treat Diseases
Prostate Cancer (Genetics) - National Effort Led To Identify Familial Cancer Gene
Respiratory Disease - Scientists Find 'Tap' Drains Liquid from Lungs at Birth
Cancer Gene Therapy - "EBV Driven Gene Therapy for EBV Associated B Cell Lymphomas."
Cancer Vaccines - "Successful and Effective In Vitro Transduction of Cord Blood Isolated T-Cells and Tumor Cell Lines with an Interleukin-12 (IL-12) Producing Retrovirus: Implications for Future Molecu
Therapy (Leukemia) - "Apoptotic Killing of Chemotherapy and Radiation-Resistant Human Myeloid Leukemias by a Recombinant Fusion Toxin Targeted to the Granulocyte-Macrophage Colony Stimulating Factor Receptor."
Genetic Engineering - "Genetic Engineering of Carbohydrate Biosynthetic Pathways in Transgenic Mice Demonstrates Cell Cycle-Associated Regulation of Glycoconjugate Production in Small Intestinal Epithelial Cells."
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.